Related Experiment Video
Updated: Jul 6, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Summary
Raltegravir targets a new viral mechanism, making it effective against HIV strains resistant to other drugs. This offers a new treatment option for drug-resistant HIV infections.
Area of Science:
- Virology
- Drug Discovery
- HIV Research
Background:
- Current antiretroviral therapies face challenges with drug-resistant human immunodeficiency virus (HIV) strains.
- Novel therapeutic targets are crucial for overcoming treatment resistance in HIV.
- Raltegravir represents a new class of antiretroviral agents targeting a unique viral enzyme.
Discussion:
- Raltegravir's mechanism of action involves inhibiting the integrase enzyme, a critical component of the HIV replication cycle.
- This novel target confers activity against HIV isolates that exhibit resistance to other antiretroviral drug classes, including nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs).
- The drug's efficacy in multidrug-resistant HIV cases highlights its potential clinical utility.
Key Insights:
- Raltegravir demonstrates potent antiviral activity against HIV, including strains resistant to established therapies.
- The drug's novel mechanism of action provides a valuable option for salvage therapy in patients with limited treatment choices.
- Sensitivity to raltegravir is observed even in HIV isolates with mutations conferring resistance to multiple antiretroviral drug classes.
Outlook:
- Further clinical evaluation of raltegravir in diverse patient populations with resistant HIV is warranted.
- Raltegravir's success may pave the way for the development of other integrase inhibitors and novel antiretroviral agents.
- Understanding resistance pathways to raltegravir will be essential for guiding long-term treatment strategies.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...